Morgan Stanley Forward Pharma A/S Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.25 - $4.65 $62,725 - $89,745	-19,300 Reduced 10.57%	163,299 $483,000
Q2 2022 Oct 27, 2022	SELL	$4.24 - $6.03 $3,472 - $4,938	-819 Reduced 0.45%	182,599 $822,000
Q2 2022 Aug 15, 2022	SELL	$4.24 - $6.03 $3,472 - $4,938	-819 Reduced 0.45%	182,599 $822,000
Q1 2022 Oct 27, 2022	BUY	$5.06 - $6.15 $4,144 - $5,036	819 Added 0.45%	183,418 $1.07 Million
Q1 2022 May 13, 2022	SELL	$5.06 - $6.15 $24,697 - $30,018	-4,881 Reduced 2.59%	183,418 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$5.43 - $7.01 $31,656 - $40,868	-5,830 Reduced 3.0%	188,299 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$5.97 - $17.66 $1.16 Million - $3.43 Million	194,129 New	194,129 $1.32 Million

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.